Defence Therapeutics
(OTC) DTCFF
Defence Therapeutics Financials at a Glance
Market Cap
$21.32M
Revenue (TTM)
$0.00
Net Income (TTM)
$4.18M
EPS (TTM)
$-0.06
P/E Ratio
-6.43
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.37
Volume
6,950
Open
$0.42
Price
$0.37
Volume
6,950
Open
$0.42
Previous Close
$0.37
Daily Range
$0.37 - $0.42
52-Week Range
$0.31 - $0.78
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.37
Volume
6,950
Open
$0.42
Previous Close
$0.37
Daily Range
$0.37 - $0.42
52-Week Range
$0.31 - $0.78
DTCFF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Defence Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Sébastien Plouffe
Website
www.defencetherapeutics.comHeadquarters
Vancouver, BC V6C 3L6, CA
DTCFF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-16%
Return on Assets
-3%
Earnings Yield
-15.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$21.32M
Shares Outstanding
57.37M
Volume
6.95K
Short Interest
0.00%
Avg. Volume
6.73K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.00M
EBITDA
$2.93M
Operating Cash Flow
$3.00M
Capital Expenditure
$0.00
Free Cash Flow
$3.00M
Cash & ST Invst.
$1.23M
Total Debt
$1.50M
Defence Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$9.27K
N/A
Gross Margin
0.00%
N/A
Market Cap
$21.32M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.52M
-88.9%
EBITDA
$1.40M
-106.5%
Quarterly Fundamentals
Net Cash
$539.92K
+53.2%
Accounts Receivable
$222.50K
+384.9%
Inventory
$0.00
N/A
Long Term Debt
$1.49M
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-3.17%
N/A
Return on Invested Capital
-15.74%
N/A
Free Cash Flow
$1.39M
-108.4%
Operating Cash Flow
$1.40M
-109.3%